Manulife Financial Corporation (MFC)
NYSE: MFC · Real-Time Price · USD
30.45
-0.51 (-1.65%)
Aug 1, 2025, 4:00 PM - Market closed
CTI BioPharma Analyst Ratings
Total Analysts
1
Consensus Rating
Buy
Price Target
$51.00
Upside
+67.49%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $49 → $51 | Buy | Maintains | $49 → $51 | +67.49% | Feb 21, 2025 |
| TD Securities | TD Securities | Strong Buy Maintains $38 → $40 | Strong Buy | Maintains | $38 → $40 | +31.36% | Jun 28, 2024 |
| BMO Capital | BMO Capital | Hold → Buy Upgrades $31 → $35 | Hold → Buy | Upgrades | $31 → $35 | +14.94% | Feb 15, 2024 |
| Barclays | Barclays | Buy Maintains $31 → $33 | Buy | Maintains | $31 → $33 | +8.37% | Aug 11, 2023 |
| RBC Capital | RBC Capital | Hold Maintains $26 → $28 | Hold | Maintains | $26 → $28 | -8.05% | Feb 17, 2023 |
| Scotiabank | Scotiabank | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Jul 27, 2022 |
| Credit Suisse | Credit Suisse | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 10, 2021 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $27 → $26 | Hold | Maintains | $27 → $26 | -14.61% | Jul 11, 2018 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $28 → $27 | Hold | Maintains | $28 → $27 | -11.33% | Apr 5, 2018 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $29 → $28 | Hold | Maintains | $29 → $28 | -8.05% | Feb 22, 2018 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $27 → $28 | Hold | Maintains | $27 → $28 | -8.05% | Nov 13, 2017 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $26 → $27 | Hold | Maintains | $26 → $27 | -11.33% | Oct 5, 2017 |
| Credit Suisse | Credit Suisse | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 14, 2016 |
| Credit Suisse | Credit Suisse | Hold → Buy Upgrades $15 → $18 | Hold → Buy | Upgrades | $15 → $18 | -40.89% | May 3, 2013 |